NEW YORK (360Dx) – Ortho Clinical Diagnostics announced today that it has signed an international distribution and copromotion agreement covering 14 assays with Thermo Fisher Scientific.

Under the terms of the deal, the companies will deliver assays for monitoring therapeutics, immunosuppressants, and drugs of abuse to hospitals, hospital networks, and labs that use Ortho's Vitros 4600 chemistry system and Vitros 5600 integrated system. The assays will initially be launched in North America, Europe, Africa, and the Middle East.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 


In this webinar, Dr. Wendy Béguelin of Weill Cornell Medicine will discuss how she used the BD Rhapsody single-cell RNA-seq platform and YFP floxed reporter mouse models to study how lymphoma-associated mutations disrupt the immune system by affecting GC B-cell states, explaining the biology of initiation of low-grade follicular lymphoma.

Sponsored by

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.